Human Technopole signs an agreement with the University of Naples Federico II
In these days we have finalised the agreement with the University of Naples Federico II that will allow the implementation of many synergies. In particular, the agreement allows for the exchange of research staff at all levels and the development of collaborative projects in areas of common interest. Moreover, the involvement in training activities and the development of joint seminars, symposia and workshops will be promoted.
At Human Technopole we want to contribute to the progress of the country, acting as a reference point for the Italian scientific community, and we are committed to raising the profile of the Italian biomedical community through partnerships and collaborations with national and international subjects.
For these reasons, we have signed several MoUs and created strategic partnerships with authoritative realities in the field of life sciences. We are Associate Partners of LifeTime, the pan-European research initiative that aims to revolutionize health care through the understanding and monitoring of single-cell resolution human diseases to transform patient care and the sustainability of health systems. We collaborate with the Department of Biology of the University of Rome “Tor Vergata” to continue the development of MINT and SIGNOR, two databases that over time have become fundamental resources for the European bioinformatics community and we have signed an MoU with the National Life Science Technology Cluster Alisei (Advanced Life Science in Italy) and with the CL.uster A.grifood N.azionale (CL.A.N) in order to develop and promote the life sciences and agri-food sectors at national and international level. Finally, we have a framework agreement with the University of Milan and we are involved in the PhD program of SEMM (European School of Molecular Medicine), becoming a host institute for the PhD program in Systems Medicine.
Share:
You could also like:
-
Colorectal Cancer: ML Enhances Cetuximab Response Predictions
An international collaborative study led by Human Technopole, Candiolo Cancer Institute IRCCS in Turin, the University of Turin, and the Wellcome Sanger Institute in Cambridge (UK) has identified new factors associated with therapeutic response in colorectal cancer. The research has led to the development of a machine-learning model capable of accurately predicting the effects of cetuximab, a drug in clinical use, on different colorectal tumour subtypes. Funded by the AIRC Foundation, the study paves the way to identifying molecular features that could serve as biomarkers for predicting treatment response in patients with this type of cancer.
-
Human Technopole Foundation’s Supplier List online
The Human Technopole Foundation’s Supplier Register is now online.
-
HT Director Zerial Awarded Mercurio Prize for Excellence in Research
The Human Technopole Director, Marino Zerial, has been awarded the 2024 Mercurio Prize in the “Research and Development” category, in recognition of the excellence of his research in the field of cell biology. Zerial, renowned for his studies on the mechanisms of endocytosis and cellular transport, has made significant contributions to the understanding of cellular dynamics, with potential therapeutic applications for diseases such as liver conditions.
-
A new model system for cortical development in vitro
Researchers from Human Technopole, the Institute of Molecular Biotechnology and Bicocca University established a method for developing brain assembloids that allows reproducing salient aspects of the antero-posterior polarity of the human cerebral cortex in vitro and opens new possibilities for disease modelling. The study is published in Nature Methods.
-
The National Facility for Genomics with Clelia Peano
Meet Clelia Peano, Head of the National Facility for Genomics. The Facility offers cutting-edge services to develop robust experimental and analytical workflows to explore different genomic research areas, including DNA and RNA analysis, chromatin structure, and epigenetic mechanisms regulating transcription. The goal is to enhance genomic research in all its aspects, benefiting the entire Italian scientific community.